172 related articles for article (PubMed ID: 17699305)
1. Corticosteroids and kidney transplantation.
Curtis J
Clin J Am Soc Nephrol; 2006 Sep; 1(5):907-8. PubMed ID: 17699305
[No Abstract] [Full Text] [Related]
2. Effect of prednisone versus no prednisone as part of maintenance immunosuppression on long-term renal transplant function.
Gallon LG; Winoto J; Leventhal JR; Parker MA; Kaufman DB
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1029-38. PubMed ID: 17699323
[TBL] [Abstract][Full Text] [Related]
3. Strategies in immunosuppression after heart transplantation: is less better?
Kobashigawa JA
Circ Heart Fail; 2011 Mar; 4(2):111-3. PubMed ID: 21406677
[No Abstract] [Full Text] [Related]
4. Mycofenolate mofetil-cyclosporine immunosuppression of kidney transplantation recipients with two different corticosteroid doses.
Remport A; Sasvári I; Toronyi E; Borka P; Lázár N; Járay J; Perner F
Transplant Proc; 2001 May; 33(3):2302-3. PubMed ID: 11377537
[No Abstract] [Full Text] [Related]
5. Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation.
Kim HC; Park SB; Kim HT; Cho WH; Park CH
Transplant Proc; 2000 Nov; 32(7):1751-2. PubMed ID: 11119919
[No Abstract] [Full Text] [Related]
6. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
[No Abstract] [Full Text] [Related]
7. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
Leichtman AB
N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
[No Abstract] [Full Text] [Related]
8. Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group.
Miller J
Transplant Proc; 1999; 31(1-2):276-7. PubMed ID: 10083106
[No Abstract] [Full Text] [Related]
9. Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.
Sola E; Alférez MJ; Cabello M; Burgos D; González Molina M
Transplant Proc; 2002 Aug; 34(5):1689-90. PubMed ID: 12176537
[No Abstract] [Full Text] [Related]
10. Steroid withdrawal from tacrolimus-based therapy in renal transplant patients.
Citterio F; Rigotti P; Scatà MC; Romagnoli J; Baldan N; Marchini F; Castagneto M
Transplant Proc; 2002 Aug; 34(5):1707-8. PubMed ID: 12176545
[No Abstract] [Full Text] [Related]
11. [Improved immunosuppression leads to better kidney transplantations].
Ekberg H
Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1739-42. PubMed ID: 23097879
[No Abstract] [Full Text] [Related]
12. Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.
Mao PC; Lee EK; Tseng PL
Transplant Proc; 2012 Jan; 44(1):185-9. PubMed ID: 22310611
[TBL] [Abstract][Full Text] [Related]
13. New immunosuppressive agents: a way to get rid of corticosteroids?
Morelon E; Kreis H
Transplantation; 2000 Nov; 70(9):1271-2. PubMed ID: 11087138
[No Abstract] [Full Text] [Related]
14. Low systemic exposure to tacrolimus correlates with acute rejection.
Undre NA; van Hooff J; Christiaans M; Vanrenterghem Y; Donck J; Heeman U; Kohnle M; Zanker B; Land W; Morales JM; Andrés A; Schäfer A; Stevenson P
Transplant Proc; 1999; 31(1-2):296-8. PubMed ID: 10083114
[No Abstract] [Full Text] [Related]
15. Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression.
Alarcón-Zurita A; Munar MA; Losada P; Morey A; Martinez J; de la Prada FJ; Marco J
Transplant Proc; 2002 Feb; 34(1):118-9. PubMed ID: 11959216
[No Abstract] [Full Text] [Related]
16. Replacement of corticosteroids by mycophenolate mofetil in liver graft recipients on initial tacrolimus immunosuppression.
Ringe B; Braun F; Wietzke P; Oellerich M; Ramadori G
Transplant Proc; 2000 Nov; 32(7):2543. PubMed ID: 11120285
[No Abstract] [Full Text] [Related]
17. Long-term steroid side effects in renal transplantation need a safe steroid withdrawal: a single-center experience.
Bertoni E; Zanazzi M; Rosati A; Di Maria L; Moscarelli L; Piperno R; Conti P; Dedola G; Bandini S; Tosi P; Salvadori M
Transplant Proc; 1998 Jun; 30(4):1303-4. PubMed ID: 9636528
[No Abstract] [Full Text] [Related]
18. Evaluation of immunosuppressive induction regimens in renal transplantation. Collaborative Transplant Study.
Opelz G
Transplant Proc; 1998 Dec; 30(8):4029-30. PubMed ID: 9865286
[No Abstract] [Full Text] [Related]
19. Immunosuppressive effect of RS-61443 on rat cardiac allograft survival in combination with leflunomide or FK 506.
D'Silva M; Antoniou E; DeRoover A; Nishimura Y; Howie A; McMaster P
Transplant Proc; 1996 Apr; 28(2):930-1. PubMed ID: 8623467
[No Abstract] [Full Text] [Related]
20. Safe withdrawal of corticosteroids or mycophenolate mofetil: results of a large, prospective, multicenter, randomized study.
Squifflet JP; Vanrenterghem Y; van Hooff JP; Salmela K; Rigotti P;
Transplant Proc; 2002 Aug; 34(5):1584-6. PubMed ID: 12176495
[No Abstract] [Full Text] [Related]
[Next] [New Search]
